Kokkinopoulos D, Trangas T, Perez S, Tsiapalis C M, Papamichail M
Leuk Res. 1986;10(11):1341-5. doi: 10.1016/0145-2126(86)90343-7.
The effect of glucocorticosteroids upon the poly(A) synthetic and degrading activity has been studied in steroid sensitive and resistant human leukemic cell lines. At least a two-fold increase in the levels of poly(A) polymerase activity was found in soluble, cytoplasmic extracts from the steroid sensitive human malignant T-cells of the MOLT3 line after 24-h treatment with dexamethasone. Longer exposure time of the cultured cells to the steroid resulted in a gradual decrease of the poly(A) polymerase activity level. Pretreatment of the cells with progesterone, a competitive inhibitor of dexamethasone, prevented the dexamethasone induced increase in the level of poly(A) polymerase activity, while progesterone alone had no effect on the enzyme level. In contrast, the levels of poly(A) nucleases activity remained constant following steroid treatment. In the steroid resistant human leukemic B-cell line Daudi no alterations in the poly(A) metabolizing enzymes could be measured in response to dexamethasone. Thus we suggest that poly(A) polymerase levels may be used to predict sensitivity of leukemic cells to glucocorticosteroid treatment.
在类固醇敏感和耐药的人白血病细胞系中,研究了糖皮质激素对多聚腺苷酸(poly(A))合成和降解活性的影响。用地塞米松处理24小时后,在MOLT3系类固醇敏感的人恶性T细胞的可溶性细胞质提取物中,发现多聚腺苷酸聚合酶活性水平至少增加了两倍。培养细胞与类固醇的接触时间延长导致多聚腺苷酸聚合酶活性水平逐渐下降。用孕酮(地塞米松的竞争性抑制剂)预处理细胞,可阻止地塞米松诱导的多聚腺苷酸聚合酶活性水平升高,而单独使用孕酮对酶水平没有影响。相反,类固醇处理后,多聚腺苷酸核酸酶活性水平保持不变。在类固醇耐药的人白血病B细胞系Daudi中,未检测到多聚腺苷酸代谢酶对地塞米松有任何变化。因此,我们认为多聚腺苷酸聚合酶水平可用于预测白血病细胞对糖皮质激素治疗的敏感性。